3,5,3′-Triiodo-L-thyronine enhances the differentiation of a human pancreatic duct cell line (hPANC-1) towards a β-cell-Like phenotype
The thyroid hormone, 3,5,3′‐Triiodo‐L‐thyronine (T3), is essential for growth, differentiation, and regulation of metabolic functions in multicellular organisms, although the specific mechanisms of this control are still unknown. In this study, treatment of a human pancreatic duct cell line (hPANC‐1...
Saved in:
Published in | Journal of cellular physiology Vol. 204; no. 1; pp. 286 - 296 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.07.2005
|
Subjects | |
Online Access | Get full text |
ISSN | 0021-9541 1097-4652 |
DOI | 10.1002/jcp.20293 |
Cover
Loading…
Summary: | The thyroid hormone, 3,5,3′‐Triiodo‐L‐thyronine (T3), is essential for growth, differentiation, and regulation of metabolic functions in multicellular organisms, although the specific mechanisms of this control are still unknown. In this study, treatment of a human pancreatic duct cell line (hPANC‐1) with T3 blocks cell growth by an increase of cells in G0/G1 cell cycle phase and enhances morphological and functional changes as indicated by the marked increase in the synthesis of insulin and the parallel decrease of the ductal differentiation marker cytokeratin19. Expression analysis of some of the genes regulating pancreatic β‐cell differentiation revealed a time‐dependent increase in insulin and glut2 mRNA levels in response to T3. As last step of the acquisition of a β‐cell‐like phenotype, we present evidence that thyroid hormones are able to increase the release of insulin into the culture medium. In conclusion, our results suggest, for the first time, that thyroid hormones induce cell cycle perturbations and play an important role in the process of transdifferentiation of a human pancreatic duct line (hPANC‐1) into pancreatic‐β‐cell‐like cells. These findings have important implications in cell‐therapy based treatment of diabetes and may provide important insights in the designing of novel therapeutic agents to restore normal glycemia in subjects with diabetes. © 2005 Wiley‐Liss, Inc. |
---|---|
Bibliography: | A.Fa.R ark:/67375/WNG-8ZD3845V-W Ministero dell'Università e della Ricerca Scientifica e Tecnologica (MIUR Cofin), Rome Italy ArticleID:JCP20293 istex:17AAFC086948E633A4830C84C2FEC26648574957 Silvia Misiti and Emanuela Anastasi contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0021-9541 1097-4652 |
DOI: | 10.1002/jcp.20293 |